Allergy Associates of the Palm Beaches

North Palm Beach, Florida 33408

0 studies enrolling now · 16 studies all time

What they study most

Agammaglobulinemia, Antibody Deficiency, Common Variable Hypogammaglobulinemia, Common Variable Immunodeficiency, Humoral Immune Response, Hypogammaglobulinemia, Immune Thrombocytopenic Purpura (ITP), Immunodeficiency With Hyper-IgM, Immunologic Deficiency Syndrome, Immunologic Deficiency Syndromes, Kawasaki Syndrome, Peanut Allergy

Studies at this site

• Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients — Completed
• Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) — Completed
• A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency — Completed
• Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16 — Completed
• Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10% — Completed
• AR101 Real-World Open-Label Extension Study — Completed
• Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) — Completed
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders — Completed
• Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) — Completed
• Phase 2/3 Study of IGSC, 20% in PIDD — Completed
• Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously — Completed
• Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) — Completed
• A Clinical Study of Intravenous Immunoglobulin — Completed
• Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency — Completed
• Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases. — Completed
• Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients — Completed